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DHX32 是人类 RNA 螺旋酶的家族成员之一，最早被发现是在急性淋巴细胞
白血病中低表达并参与淋巴细胞的分化，但是它的生物学功能尚未明确。我们课
题组前期通过差异基因显示技术发现 DHX32 在结直肠癌中表达上调，功能研究












Transwell 迁移实验和基质胶侵袭实验，进一步研究了 DHX32 对肝癌细胞迁移和
侵袭的调控作用，结果显示过表达 DHX32 促进肝癌细胞的迁移和侵袭，而敲低
DHX32 抑制肝癌细胞的迁移和侵袭。分子水平上，我们对 DHX32 促肝癌细胞转
移的作用机制进行了初步探讨，通过形态和免疫荧光染色观察，发现 DHX32 能
促进上皮-间质转化及细胞骨架重构和伪足的生成，进一步的研究表明 DHX32 能













































Hepatocellular carcinoma (HCC) is one of the most lethal cancer globally. Many 
HCC patients had tumor recurrence after clinical therapy and the 5-year survival rate 
is under 30%, which is attributed to the tumor cell invasion and metastasis, and 
effective strategies in treating tumor metastasis are sure to benefit patients. Hence, a 
growing body of research is focusing on exploring the molecular mechanism of the 
development of HCC, and hope to exploit some key regulators to prevent or target 
cancer metastasis. 
DHX32, a member of human RNA helicase, was first to be reported of 
down-regulated in acute lymphoblastic leukemia and involved in lymphocyte 
differentiation. But, it has not been clarified of its biological function. Researchs from 
our lab suggest that DHX32 was up-regulated in colorectal cancer and promoted CRC 
cell proliferation, migration, and invasion. However, the role of DHX32 in other solid 
tumors and the exact mechanism of its function has never been reported. Previous 
research of this study showed that DHX32 was over-expressed in HCC, which refers 
to another kind of malignant solid tumor, and its expression was associated with 
tumor metastasis. Therefore, this study was conducted to investigate the role of 
DHX32 in the metastasis of hepatocellular carcinoma.   
First, we detected DHX32 mRNA and protein level in hepatocellular carcinoma 
tissues and their matched normal tissues by using real-time PCR assay and 
immunohistochemistry staining, meanwhile, we analyzed the correlation between its 
expression level and the clinical pathologic features of patients. Results displayed that 
DHX32 was up-regulated in HCC tissues compared with their adjacent nomal tissues 
and its expression was associated with tumor vascular invasion and metastasis. Then, 
detection and analysis on a cellular level were carried out, RT-qPCR and western blot 
analysis showed that DHX32 expression has a positive correlation with the metastatic 
potentials of HCC cell lines. These observations suggested that DHX32 may be 
involved in the migration and invasion of HCC cells. To test this hypothesis, we used 
QGY-7701-DHX32 overexpressed cell and MHCC-97H-DHX32 shRNA knockdown 
cell with some in vitro cell function assays, including wound healing assay, transwell 
migration assay and matrigel invasion assay. Our results showed that overexpression 















inhibits HCC cell migration and invasion compared with control cells. We next sought 
to investigate the molecular mechanism of prometastatic function of DHX32. By 
cellular morphologie and immunofluorescence to observe the change of cell 
morphology and cytoskeleton, we found that DHX32 may regulating Epithelial 
Mesenchymal Transition, cytoskeleton remodeling and pseudopodia formation. CoIP 
assays demonstrated that DHX32 interact with Rac1, and further researchs confirmed 
that DHX32 up-regulates Rac1 protein expression, resulting in stronger capability for 
metastasis of HCC cells.  
Taken together, our results identified DHX32 was up-regulated in HCC tissues 
and in high metastatic potential liver cancer cells, and its expression was associated 
with tumor vascular invasion and metastasis. Overexpression of DHX32 promoted 
HCC cell migration and invasion. Subsequent investigations revealed that DHX32 
promotes EMT and upregulates Rac1 expression resulting enhanced migration and 
invasion of HCC cells. Therefore, we hold the opinion that DHX32 may act as a 
prometastatic gene in HCC, and may be a potential biomarker for higher malignant 
degree HCC cells, and deeper researchs may provide a new target for the prevention 
of metastasis of HCC.  
















缩略语 英文全称 中文名称 
HCC Hepatocellular Carcinoma 肝细胞癌 
DHX DEAH box helicase DHX 螺旋酶 
DDX DEAD box helicase DDX 螺旋酶 
EMT Epithelial-Mesenchymal transition 上皮-间质转化 
E-Ca E-Cadherin 上皮钙黏蛋白 
N-Ca N-Cadherin N-钙黏着蛋白 
Rac 
Ras-related C3 botulinum toxin 
substrate 
RaS 相关的 C3 肉毒杆菌
毒素底物 
PCR Polymerase Chain Reaction 多聚酶链反应 
RT-qPCR 




RPM Rotation per minute 转每分钟 
DEPC Diethylpyrocarbonate 焦碳酸二乙酯 
TBE Tetrabromoethane 四溴乙烷 
Amp Ampicillin 氨苄青霉素 
LB Lysogeny broth LB 培养基 
Poly Polybrene 聚凝胺 
IHC Immunohistochemistry 免疫组织化学 
PBS Phosphate-buffered saline 磷酸盐缓冲液 
WB Western blotting 蛋白免疫印迹 















TEMED Tetramethylethylenediamine 四甲基乙二胺 
APS Ammonium peroxydi-sulfate 过硫酸铵 
Gly Glycine 甘氨酸 
SDS Sodium dodecyl sulphate 十二烷基硫酸钠 
Tris Tris (hydroxymethyl) aminomethane 三羟甲基氨基甲烷 
TBS Tris Buffered Saline 
三羟甲基氨基甲烷缓冲
液 
PVDF Polyvinylidene Fluoride 聚偏氟乙烯膜 
FBS Fetal bovine serum 胎牛血清 
DMSO Dimethyl Sulfoxide 二甲基亚砜 
ECL Electrochemiluminescence 电化学发光 
HRP Horse Reddish Peroxidase 辣根过氧化物酶 
TRITC Tetramethylrhodamine 四甲基异硫氰酸罗丹明 
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